Mira Pharmaceuticals (MIRA) Liabilities and Shareholders Equity (2022 - 2025)
Mira Pharmaceuticals (MIRA) recorded Liabilities and Shareholders Equity of $11.09 million in the quarter ended Dec 31, 2025, up 279.5% from $2.92 million a year earlier and up 45.3% from the prior quarter.
Powered by 
Analysis
Mira Pharmaceuticals (MIRA) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends
Starting with the quarter ended Dec 31, 2022, Mira Pharmaceuticals' Liabilities and Shareholders Equity history includes 11 quarters.
- Annual Liabilities and Shareholders Equity has a three-year compound annual growth rate of 134.7% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $2.92 million in the year ended Dec 31, 2024 (-40.7%), $4.93 million in the year ended Dec 31, 2023 (+474.8%) and $858,074 in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2025 is the highest quarterly Liabilities and Shareholders Equity in data going back to the quarter ended Dec 31, 2022.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in two of the last five quarters, with growth averaging 40.4%.
- Per Business Quant, the preceding three quarters came in at $7.63 million (quarter ended Sep 30, 2025), $868,318 (quarter ended Jun 30, 2025) and $1.4 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Mira Pharmaceuticals | 14.69 Mn | -5.81 Mn | - | 11.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.09 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Jun 30, 2025 | 868,318.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 4.93 Mn |
| Sep 30, 2023 | 9.02 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Dec 31, 2022 | 858,074.00 |
API Access
Mira Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();